organ testing

R&D

Researchers are beginning to imagine a future in which development pipelines are more predictive, more efficient, and ultimately more humane.

News

Sobi chief executive Guido Oelkers is preparing his exit, but is still cutting deals, licensing a lymphoma drug from Innate for up to $580m.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.